203 related articles for article (PubMed ID: 22541723)
1. Recombinant bacterial vaccines.
Unnikrishnan M; Rappuoli R; Serruto D
Curr Opin Immunol; 2012 Jun; 24(3):337-42. PubMed ID: 22541723
[TBL] [Abstract][Full Text] [Related]
2. Strategies of constructing recombinant vaccines.
Sałamaszyńska-Guz A; Klimuszko D
Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. New ways to identify novel bacterial antigens for vaccine development.
Movahedi AR; Hampson DJ
Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
[TBL] [Abstract][Full Text] [Related]
5. New technologies for vaccines.
Dorner F; Eibl J; Barrett PN
Wien Klin Wochenschr; 1999 Mar; 111(5):199-206. PubMed ID: 10226350
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of vaccines against bacterial diseases in swine: what can we expect?
Haesebrouck F; Pasmans F; Chiers K; Maes D; Ducatelle R; Decostere A
Vet Microbiol; 2004 Jun; 100(3-4):255-68. PubMed ID: 15145504
[TBL] [Abstract][Full Text] [Related]
7. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
Oliveira ML; Arêas AP; Ho PL
Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered vaccines: an overview.
Dertzbaugh MT
Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
[TBL] [Abstract][Full Text] [Related]
9. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
Wu JJ; Huang DB; Pang KR; Tyring SK
J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the development of live, attenuated bacterial vectors.
Roland KL; Tinge SA; Killeen KP; Kochi SK
Curr Opin Mol Ther; 2005 Feb; 7(1):62-72. PubMed ID: 15732531
[TBL] [Abstract][Full Text] [Related]
11. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries.
Walker RI
Vaccine; 2005 May; 23(26):3369-85. PubMed ID: 15837361
[TBL] [Abstract][Full Text] [Related]
12. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
13. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
14. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccines against leptospirosis.
Dellagostin OA; Grassmann AA; Hartwig DD; Félix SR; da Silva ÉF; McBride AJ
Hum Vaccin; 2011 Nov; 7(11):1215-24. PubMed ID: 22048111
[TBL] [Abstract][Full Text] [Related]
16. Rational design of gene-based vaccines.
Barouch DH
J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
[TBL] [Abstract][Full Text] [Related]
17. Salmonella-based vaccines for infectious diseases.
Kwon YM; Cox MM; Calhoun LN
Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
[TBL] [Abstract][Full Text] [Related]
18. NMR assays for carbohydrate-based vaccines.
Jones C
J Pharm Biomed Anal; 2005 Aug; 38(5):840-50. PubMed ID: 16087046
[TBL] [Abstract][Full Text] [Related]
19. Bacterial enteric infections and vaccine development.
Holmgren J; Svennerholm AM
Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
[TBL] [Abstract][Full Text] [Related]
20. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
